TrialFrontiers in immunology2026

Evaluating the impact of leniolisib treatment on symptoms and health-related quality of life in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome.

V Koneti Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.